Risk for cancer reduced for patients with multiple sclerosis

Risk for cancer reduced for patients with multiple sclerosis

(HealthDay)—The risk for cancer is reduced among patients with multiple sclerosis (MS), according to a systematic review and meta-analysis published online Aug. 13 in Autoimmunity Reviews.

Mahsa Ghajarzadeh, M.D., M.P.H., from the Tehran University of Medical Sciences in Iran, and colleagues examined the pooled risk for in patients with MS. Data were included from five articles that met the inclusion criteria.

The researchers found that in the included articles, the risk ratio was estimated between 0.7 and 1.67, with the pooled risk ratio estimated at 0.83. In two studies, the pooled prevalence of breast cancer was 2 percent; in two studies, the pooled prevalence of digestive cancer was 2 percent; and in two studies, the pooled prevalence of skin cancer was 1 percent.

"To the best of our knowledge, this is the first study evaluating the risk of cancer in patients with MS," the authors write. "The result of this showed that the risk of cancer in patients with MS is less than the ."


Explore further

About one in three multiple sclerosis patients have migraine

More information: Abstract/Full Text (subscription or payment may be required)

Copyright © 2020 HealthDay. All rights reserved.

Citation: Risk for cancer reduced for patients with multiple sclerosis (2020, August 28) retrieved 10 April 2021 from https://medicalxpress.com/news/2020-08-cancer-patients-multiple-sclerosis.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
100 shares

Feedback to editors

User comments